On June 12, 2025, Tyler Dang, PhD represented Primrose Bio at Oxford Nanopore Technologies’ inaugural Biopharma Day in San Diego. This regional event brought together leaders in biotech to explore how real-time sequencing can accelerate biopharmaceutical research and development.
Dr. Dang shared how Primrose Bio is integrating Oxford Nanopore’s sequencing technology with our Pfenex Expression Technology® platform to improve protein characterization and support the development of complex biologics. The collaboration reflects our commitment to applying cutting-edge tools that enhance efficiency and data-driven decision-making in protein engineering.
